Results 141 to 150 of about 400,342 (335)
This study synthesized a personalized neoantigen vaccine (Neo‐CRCVAS) and combined it with regorafenib, termed RegoNeo. This combination therapy significantly enhanced antitumor efficacy and promoted long‐term tumor‐specific immune memory in microsatellite stable colorectal cancer liver metastasis (MSS‐CRLM) models by increasing neoantigen‐specific ...
Hengkai Chen+11 more
wiley +1 more source
Treatment for hepatocellular carcinoma (HCC) with esophageal varices.
Kuniaki Kojima+7 more
openalex +2 more sources
Inhibition of Tumor Lipogenesis and Growth by Peptide‐Based Targeting of SREBP Activation
A peptide that replicates the amino acid sequence in Insig1/2 loop 1 inhibits the IGF1‐induced interaction between PCK1 and Insig1/2, PCK1‐mediated phosphorylation of Insig1/2, and SREBP activity‐dependent lipid synthesis. Administration of the LNP‐Insig1/2 loop 1 peptide effectively attenuates tumor growth and sensitizes tumors to the antitumor effect
Shudi Luo+10 more
wiley +1 more source
The paradox of immunotherapy in NASH-HCC [PDF]
Jun Yu+4 more
openaire +4 more sources
The microenvironment in the development of MASLD-MASH-HCC and associated therapeutic in MASH-HCC
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a series of obesity-related metabolic liver diseases, ranging from relatively benign hepatic steatosis to metabolic-associated steatohepatitis (MASH). With the changes in lifestyle, its incidence and prevalence have risen to epidemic proportions globally. In recent years, an increasing
Qiulin Wu+4 more
openaire +3 more sources
Microphysiological Solid Tumor Models in Hydrogel Beads for CAR T Cell Immunotherapy Evaluation
The complex physical and biochemical barriers of the tumor microenvironment are major triggers of immune exclusion. Here, a 3D micrometastasis model is developed to mimic key microenvironmental cues, enabling in vitro evaluation of chimeric antigen receptor (CAR) T cell immunotherapy. Abstract Micrometastases are challenging to resect surgically and to
Xuan Peng+14 more
wiley +1 more source
mRECIST for HCC: Performance and novel refinements.
J. Llovet, R. Lencioni
semanticscholar +1 more source
HCC, diet and metabolic factors: Diet and HCC.
Hepatocellular carcinoma is the most common primary liver malignancy and is an international public health concern, constituting one of the most deadly cancers worldwide. Infection with hepatitis B virus and hepatitis C virus is a major risk factor for HCC in developed countries.
Maurizio, Montella+2 more
openaire +1 more source